# ArrowBiome Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arrowbiome-pte

- Industry: Biotechnology
- Headquarters: Singapore
- Website: www.arrowbiome.com/
- Total disclosed funding: $1M
- Latest round: Seed (Jun 25, 2024)
- Investors on record: 1

## About

Founded in 2022 by co-founders Boon Chong Goh and Maurice van Steensel and based in Singapore, ArrowBiome is developing solutions for the human microbiome that revolutionize microbiome care through their innovative approach. In June 2024, ArrowBiome Pte. Ltd. raised USD 1 million in seed funding from investors Cocoon Capital.


The company's proprietary technologies focus on lysins, which are highly selective enzymes derived from bacteriophages that can effectively burst and kill bacteria by targeting their outer cell walls. This specificity allows for customized bacterial targeting, reducing collateral damage to beneficial microorganisms and enhancing treatment precision. ArrowBiome’s proprietary platform technologies enable the engineering of lysins with desired properties, such as activity levels or broader bacterial killing spectrums.


The company will use the June 2024 funding for the growth of its research and development.

## Funding rounds

- Seed, Jun 25, 2024, $1M — Cocoon Capital

## Investors

- Cocoon Capital (https://capitalatlas.ai/funds/cocoon-capital) — Seed